永笙生技股份有限公司 News Releases

[永笙生技股份有限公司] Q1 2026 EPS -0.19 NTD

永笙生技股份有限公司 reported a Q1 2026 EPS of -0.19 NTD, with operating revenue at 88 million NTD. · 2026-03-01

[永笙生技股份有限公司] Q1 2026 EPS -0.19 NTD

永笙生技股份有限公司 reported a Q1 2026 EPS of -0.19 NTD, with operating revenue at 88 million NTD. · 2026-03-01